1 citations
,
March 2021 in “Dermatological reviews” This review discusses recent advances in understanding the pathophysiology and molecular mechanisms of androgenetic alopecia in males, females, and children, but reports no new clinical results.
8 citations
,
August 2019 in “Journal of The American Academy of Dermatology” This study found that androgenetic alopecia is a significant yet under-recognized cause of hair loss in children and adolescents, often linked to family history and typically diagnosed by clinical examination.
This article discusses androgenetic alopecia, emphasizing its prevalence, characteristics, and the importance of prompt diagnosis and treatment but reports no new clinical results.
March 2017 in “Hair transplant forum international” This study found that East and Southeast Asians exhibited lower donor hair density and more miniaturized hairs compared to West and South Asians in hair transplantation settings.
This article discusses the management of male androgenetic alopecia and reports no new clinical results; it highlights the role of psychological and technical factors and the potential of combination treatments.
This paper reviews female androgenetic alopecia and highlights the importance of differentiating it from other hair loss conditions, noting its potential association with hyperandrogenism in premenopausal women, but reports no new results.
3 citations
,
March 2014 in “Turkderm” This article reviews the causes, clinical features, and treatment options for androgenetic alopecia, but provides no new clinical findings.
January 2014 in “Jaypee Brothers Medical Publishers (P) Ltd. eBooks” This article discusses androgenetic alopecia, including its prevalence, different patterns in men and women, and variations among races, without providing new clinical findings.
January 2013 in “Jaypee Brothers Medical Publishers (P) Ltd. eBooks” 
September 2010 in “Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii” This study found that the TrichoScan Professional V3.0.8.76 shows high reproducibility in measuring hair count and density but may not be effective for distinguishing hair growth phases in women with androgenetic alopecia.
6 citations
,
October 2005 in “Indian Journal of Dermatology” The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.
4 citations
,
January 2002 in “Annals of Dermatology” This study found that among alopecia patients, 64.5% had androgenetic alopecia, with a significant prevalence in individuals under age 30 and links to family history and androgen-associated conditions.
This review discusses male androgenetic alopecia treatments, noting that topical minoxidil and oral finasteride are FDA-approved and require continuous use to maintain hair retention effects, but reports no new clinical results.
2 citations
,
August 1999 in “PubMed” 
September 1997 in “Journal of The European Academy of Dermatology and Venereology” Hormonal differences affect male pattern baldness.
September 1997 in “Journal of The European Academy of Dermatology and Venereology” New treatment improves male hair loss.
September 1997 in “Journal of The European Academy of Dermatology and Venereology” Topical spironolactone effectively treats hair loss in women.
